EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi‐marker postmortem study

Filipa M Rocha, Avishek Roy, Mukesh Varshney, Amit Kumar

Alzheimer's & Dementia · 2025-02 · 21 (2)

DOI: 10.1002/alz.14488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.02.2025. Verfasst von Filipa M Rocha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockho…. Hauptthemen laut MEDLINE: Parkinson Disease, Astrocytes, Selegiline, Gliosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gunvor och Josef Anérs Stiftelse, Vinnova grant on Emerging Technology solutions : 2023-01471, the private initiative "Innovative ways to fight Alzheimer's disease - Leif Lundblad Family and others.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Despite significant astrocytic involvement in Parkinson's disease (PD), the knowledge regarding the role of reactive astrogliosis is still at the surface level; largely due to lack of specific biomarkers to track these processes. Novel astroglial PET‐tracers BU99008 and Deprenyl, hold immense potential for visualizing reactive astrogliosis in PD. However, they have not been thoroughly investigated in PD. METHODS We employed a multi‐marker approach and performed in vitro radioligand binding and autoradiography studies with 3 H‐BU99008 and 3 H‐Deprenyl together with astrocytic immunofluorescence and morphometric analyses in the frontal cortex, temporal cortex, caudate and putamen brain regions of PD ( n = 4) and control ( n = 7) cases. RESULTS AND DISCUSSION 3 H‐BU99008 and 3 H‐Deprenyl showed distinct binding behavior and displayed a diverse array of binding sites (single or multiple) in PD and control brains. Importantly, 3 H‐BU99008 and 3 H‐Deprenyl autoradiography studies captured pronounced reactive astrogliosis in PD brain regions, corroborated by marked changes in astrocytic markers, morphology, and cellular processes. Highlights Astroglial tracers BU99008 and Deprenyl displayed a range of binding sites with different levels of affinity and proportions (%) in healthy control (CN) and Parkinson's disease (PD) brains. Astroglial tracers BU99008 and Deprenyl showed a highly specific (permanent) high‐affinity (HA) binding site in the nanomolar range, which might be consistent across different pathologies. Astroglial tracers BU99008 and Deprenyl highlighted distinct tracer binding behavior, indicating that they might be targeting different subpopulations or specific states of astrocytes in CN and PD brains. Astroglial tracers BU99008 and Deprenyl captured prominent reactive astrogliosis at the advanced/end stages of PD, substantiated by a significant increase in intercellular adhesion molecule 1 (ICAM‐1)–positive reactive astrocytes and marked changes in astrocytic morphology and processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseAstrocytesSelegilineGliosisBrainHumansMaleAgedFemaleAutoradiographyMiddle AgedPositron-Emission TomographyBiomarkersAged, 80 and over

Stichwörter der Autor:innen

BU99008DeprenylGFAPICAM‐1Parkinson's disease (PD)astrocytesastroglial PET tracersbiomarkerspostmortem brainsreactive astrogliosis

Substanzen

SelegilineBiomarkers

Autor:innen und Institutionen

  • Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
  • Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Förderung

  • Gunvor och Josef Anérs Stiftelse
  • Vinnova grant on Emerging Technology solutions : 2023-01471
  • the private initiative "Innovative ways to fight Alzheimer's disease - Leif Lundblad Family and others
  • Karolinska geriatrics foundation
  • Loo och Hans Ostermans Stiftelse för Medicinsk Forskning
  • Tore Nilsons Stiftelse för Medicinsk Forskning
  • Åhlén-stiftelsen
  • Stiftelsen Sigurd and Elsa Goljes Minne

Zitieren

APA

Rocha, F. M., Roy, A., Varshney, M., & Kumar, A. (2025). Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi‐marker postmortem study. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14488

Vancouver

Rocha FM, Roy A, Varshney M, Kumar A. Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi‐marker postmortem study. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14488

BibTeX
@article{Rocha2025,
  author = {Rocha, Filipa M and Roy, Avishek and Varshney, Mukesh and Kumar, Amit},
  title = {Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi‐marker postmortem study},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {2},
  doi = {10.1002/alz.14488}
}
Kostenlos starten →